IP Library › Granted Patent US 11,597,903
Granted Patent B2
US 11,597,903 · App. 15/577,415 · Granted Mar 7, 2023

Cell-controlled perfusion in continuous culture

Inventors: Gregory Walter Hiller (Wakefield, MA); Matthew Paul Gagnon (Medford, MA); Ana Maria Ovalle (Medford, MA)
Assignee: Boehringer Ingelheim International GmbH
C12M29/10C12M41/26C12N5/0018C12N5/0062C12N2500/60C12N2510/02C12N2511/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,597,903
App. No.
15/577,415
Granted
Mar 7, 2023
Kind
B2
Abstract

Methods of protein production in continuous perfusion mammalian cell culture bioreactors are provided. Methods for continuous perfusion culture by allowing cells to self-regulate the rate of addition of perfusion medium to the bioreactor via a pH change are presented. Compositions comprising the perfusion medium as well as the process advantages of using hi-end pH control of perfusion or HIPCOP are also presented.

Claims (17)

1. A continuous perfusion culture process, comprising:

a) monitoring pH in a cell culture with a pH sensor, wherein the cell culture comprises mammalian cells;

b) delivering fresh medium and removing permeate when the pH is above a predetermined value; and

c) deactivating the medium delivery and the permeate removal when the pH is below the predetermined value,

wherein the fresh medium comprises glucose and L-lactate, and

wherein the cells control their perfusion rate over the entire continuous perfusion period by taking up lactic acid when the glucose level in the cell culture becomes limiting, and excreting lactic acid when the glucose level in the cell culture becomes non-limiting.

2. The process according to claim 1 , wherein the L-lactate is present in the fresh medium in an amount of about 0.1 g/L to 7.0 g/L.

3. The process according to claim 1 , wherein the L-lactate is sodium L-lactate or potassium L-lactate.

4. The process according to claim 1 , wherein the fresh medium further comprises:

amino acids.

5. The process according to claim 1 , wherein the fresh medium comprises:

(a) between about 0.5 and 40 g/L glucose;

(b) between about 0.1 and 7 g/L L-lactate; and

(c) amino acids in a ratio of between about 0.25 and 1.0 mole glucose to mole amino acids.

6. The process according to claim 4 , wherein the amino acids and glucose are provided in an amount equal to 70 mM amino acids and 5.3 grams of glucose per liter of medium or at ratios selected from the group consisting of 60:4.2; 90:8; 100:12; 120:13; 240:42 and 380:70 mM amino acids:grams/L glucose per liter of medium.

7. The process according to claim 1 , wherein the predetermined value is about pH 7.

8. The process according to claim 1 , wherein during the course of culturing the cells the lactate concentration of the cell culture drops to 2 g/L after 3 days of culture, and the lactate concentration remains below 2 g/L for the duration of the continuous perfusion process.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2018
From: PFIZER INC.
To: BOEHRINGER INGELHEIM BIOPHARMACEUTICALS GMBH
Reel/Frame 047117/0985 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2018
From: BOEHRINGER INGELHEIM BIOPHARMACEUTICALS GMBH
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 047118/0170 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2018
From: HILLER, GREGORY WALTER; GAGNON, MATTHEW PAUL; OVALLE, ANA MARIA
To: PFIZER INC.
Reel/Frame 047107/0150 →
Continuity (4)
Provisional Application 62246774 · Oct 27, 2015
Provisional Application 62199388 · Jul 31, 2015
Provisional Application 62168297 · May 29, 2015
Related Publication 20180171279A1 · Jun 21, 2018